Point-of-Care Testing (POCT) Devices Market is expected to grow at a CAGR of 10.12% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Point-of-Care Testing (POCT) Devices Market size was valued at USD 45.4 billion in 2022 growing at a CAGR of 10.12% from 2023 to 2033.
• North America dominated the market in 2022
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global Point-of-Care Testing (POCT) Devices Market size accounted for USD 11.78 Billion in 2022, growing at a CAGR of 8.30% from 2023 to 2033. The Point-of-Care Testing (POCT) Devices market involves the development and distribution of medical diagnostic devices designed for rapid on-site testing, typically outside of traditional laboratory settings. These devices provide quick and convenient results, enabling healthcare professionals to make immediate decisions for patient care. The market spans various medical disciplines, including infectious diseases, cardiac markers, and pregnancy testing. Key drivers include the need for faster diagnosis, decentralized testing in remote or resource-limited areas, and the growing trend towards personalized medicine. The POCT market plays a crucial role in improving healthcare accessibility and efficiency.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=openpr.com&reportCode=021737

The Point-of-Care Testing (POCT) Devices market is driven by the increasing demand for rapid and decentralized diagnostic solutions, allowing immediate medical decision-making. Factors such as the need for quicker results, especially in emergency and remote settings, and the trend towards personalized medicine contribute to market growth. POCT devices play a pivotal role in enhancing healthcare accessibility and efficiency by providing on-the-spot testing across various medical disciplines.

Key Players
Some of the major Point-of-Care Testing (POCT) Devices Market players holding high market shares include Microsoft Corporation, Oracle Corporation, SAP SE, SAS Institute Inc., and TIBCO Software Inc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include F. Hoffmann-La Roche Ltd, Becton Dickinson & Company, Cepheid (Danaher), Siemens Healthineers, Abbott, Diasorin S.p.a., Thermo Fisher Scientific Inc., Qiagen, BIOMÉRIEUX, Hologic Inc., Bio Rad Laboratories, Quidel Corporation, EKF Diagnostics, SEKISUI Diagnostics, DiaSys-Diagnostic Systems GmbH, InBios International, Inc., Jiangsu Mole Bioscience Co., Ltd., ACON Laboratories, Inc., Visby Medical, Inc. and UNIMA, INC.

Report Description: https://report.evolvebi.com/index.php/sample/request?referer=openpr.com&reportCode=021737

Segmental Analysis
Based on Product, the Point-of-Care Testing (POCT) Devices market is segmented into Dipstick, Strips & Cards, Cassettes and Handheld POC Monitoring Devices.
Based on Sample, the Point-of-Care Testing (POCT) Devices market is segmented into Saliva, Nasal Swabs, Urine, Blood, Plasma, Sweat and Other Fluids.
Based on Test Type, the Point-of-Care Testing (POCT) Devices market is segmented into COVID-19 Testing, Glucose Testing, Hb1Ac Testing, Coagulation Testing, Pregnancy & Fertility Testing, Allergy Tests, Cholesterol & Lipids Tests, Drug of Abuse (DOA) Testing, Food Sensitivity Tests, Metabolism Tests, Vitamin D Tests, Vitamins B Test, Urinary Tract Infection (UTI) Tests, Sexual Health Tests, Water Testing Kits, Alcohol Tests and Others.
Based on End User, the Point-of-Care Testing (POCT) Devices market is segmented into Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings, Non-Government Organization, Government & Federal Agencies and Long Term Care Centers

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.